MedPath

The effect of anti-VEGF treatments for neovascular,exudative and inflammatory ocular diseases

Not Applicable
Recruiting
Conditions
Ocular diseases including neovascular, serous and inflammatory diseases
Registration Number
JPRN-UMIN000021589
Lead Sponsor
The department of ophthalmology,Tohoku university graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
3000
Inclusion Criteria

Not provided

Exclusion Criteria

Children, and adults who can not understand this study or do not have a consciousness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual prognosis including visual acuity after intravitreal anti-VEGF drugs
Secondary Outcome Measures
NameTimeMethod
The intraocular inflammatory mediators including cytokines and chemokines The intraocular metabolomic profile including reactive polysulfide species.
© Copyright 2025. All Rights Reserved by MedPath